TruSpine Technolgs. - Issue of Equity

25 April 2025

TruSpine Technologies plc

("TruSpine" or the "Company")

Issue of Equity

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that on 28 March 2025, the Company issued 7,103,623 new ordinary shares ("Creditor Shares") of 0.01 pence each at a price of 1.5 pence per Creditor Share to settle creditor liabilities of approximately £106,554. Due to an administrative oversight by the Company, no announcement or application was made for these shares to be admitted to trading on the AQSE Market.

Admission

Application has now been made for the Creditor Shares to be admitted to trading on the Aquis Stock Exchange AQSE Growth Market on or around 1 May 2025 ("Admission") and will rank pari passu with the ordinary shares of the Company in issue.

Total Voting Rights

Following Admission, the Company's issued share capital will comprise 160,131,523 ordinary shares of 0.01p each, with each share carrying the right to one vote, therefore the total number of voting rights in the Company will be 160,131,523. This figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in the Company, or a change to their interest in the Company, under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

-END-

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.